Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and pr...

por Nash, Peter, Behrens, Frank, Orbai, Ana-Maria, Rathmann, Suchitrita S, Adams, David H, Benichou, Olivier, Deodhar, Atul
Publicado 2018

Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks

por Tepper, Stewart J., Vasudeva, Raghavendra, Krege, John H., Rathmann, Suchitrita S., Doty, Erin, Vargas, Bert B., Magis, Delphine, Komori, Mika
Publicado 2020

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial

por Burmester, Gerd-Rűdiger, Kivitz, Alan J, Kupper, Hartmut, Arulmani, Udayasankar, Florentinus, Stefan, Goss, Sandra L, Rathmann, Suchitrita S, Fleischmann, Roy M
Publicado 2015

Spinal Inflammation in the Absence of Sacroiliac Joint Inflammation on Magnetic Resonance Imaging in Patients With Active Nonradiographic Axial Spondyloarthritis

por van der Heijde, Désirée, Sieper, Joachim, Maksymowych, Walter P, Brown, Matthew A, Lambert, Robert G W, Rathmann, Suchitrita S, Pangan, Aileen L
Publicado 2014

Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies

por Smith, Timothy, Krege, John H., Rathmann, Suchitrita S., Dowsett, Sherie A., Hake, Ann, Nery, Emel S. M., Matthews, Brandy R., Doty, Erin G.
Publicado 2020

Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis

por Gladman, Dafna D., Orbai, Ana-Maria, Klitz, Uta, Wei, James Cheng-Chung, Gallo, Gaia, Birt, Julie, Rathmann, Suchitrita, Shrom, David, Marzo-Ortega, Helena
Publicado 2019

Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab

por van der Heijde, Désirée, Breban, Maxime, Halter, Dale, DiVittorio, Gino, Bratt, Johan, Cantini, Fabrizio, Kary, Sonja, Pangan, Aileen L., Kupper, Hartmut, Rathmann, Suchitrita S., Sieper, Joachim, Mease, Phillip J.
Publicado 2015

Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1)

por Chandran, Vinod, van der Heijde, Désirée, Fleischmann, Roy M, Lespessailles, Eric, Helliwell, Philip S, Kameda, Hideto, Burgos-Vargas, Ruben, Erickson, Janelle S, Rathmann, Suchitrita S, Sprabery, Aubrey Trevelin, Birt, Julie A, Shuler, Catherine L, Gallo, Gaia
Publicado 2020